Sichuan Hebang Biotechnology Co Ltd Cash Flow-to-Debt Ratio
Sichuan Hebang Biotechnology Co Ltd cash flow-to-debt ratio. Sichuan Hebang Biotechnology Co Ltd (603077) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥165.40 Million could theoretically repay 0% of its total liabilities (CN¥10.53 Billion) in one year. Check 603077 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Cash flow-to-debt ratio of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. Historical debt coverage capacity for Sichuan Hebang Biotechnology Co Ltd across 17 annual periods. Check Sichuan Hebang Biotechnology Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sichuan Hebang Biotechnology Co Ltd Cash Flow-to-Debt Ratio by Year (2009–2025)
Sichuan Hebang Biotechnology Co Ltd cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for Sichuan Hebang Biotechnology Co Ltd. For the full cash flow conversion analysis, see 603077 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥1.08 Billion | CN¥10.25 Billion | ▲ +138.8% |
| 2024 | 0.04x | CN¥467.93 Million | CN¥10.64 Billion | ▼ -5.3% |
| 2023 | 0.05x | CN¥200.76 Million | CN¥4.32 Billion | ▼ -92.4% |
| 2022 | 0.61x | CN¥2.64 Billion | CN¥4.34 Billion | ▼ -37.4% |
| 2021 | 0.97x | CN¥3.20 Billion | CN¥3.29 Billion | ▲ +805.6% |
| 2020 | 0.11x | CN¥368.85 Million | CN¥3.43 Billion | ▲ +99.9% |
| 2019 | 0.05x | CN¥162.92 Million | CN¥3.03 Billion | ▼ -88.1% |
| 2018 | 0.45x | CN¥944.39 Million | CN¥2.09 Billion | ▲ +368.7% |
| 2017 | 0.10x | CN¥176.94 Million | CN¥1.83 Billion | ▼ -63.9% |
| 2016 | 0.27x | CN¥575.26 Million | CN¥2.15 Billion | ▲ +174.7% |
| 2015 | 0.10x | CN¥449.20 Million | CN¥4.62 Billion | ▲ +108.3% |
| 2014 | 0.05x | CN¥204.67 Million | CN¥4.38 Billion | ▲ +126.3% |
| 2013 | -0.18x | CN¥-407.48 Million | CN¥2.29 Billion | ▼ -316.2% |
| 2012 | 0.08x | CN¥134.96 Million | CN¥1.64 Billion | ▼ -65.2% |
| 2011 | 0.24x | CN¥552.56 Million | CN¥2.34 Billion | ▲ +53.0% |
| 2010 | 0.15x | CN¥330.77 Million | CN¥2.14 Billion | ▲ +443.4% |
| 2009 | 0.03x | CN¥68.97 Million | CN¥2.43 Billion | — |